Researchers at Penn State College of Medicine, working with Chinese and American colleagues, have discovered a novel way to enhance and
restore cancer suppressor activity in B - cell acute lymphoblastic leukemia, resulting in better outcomes in a pre-clinical model of the disease.
The findings provide proof of principle that
restoring the function of a single tumor
suppressor gene can cause tumor regression and suggest future avenues for developing effective
cancer treatments.